105.50
0.00
(0.00%)
At close: January 17 at 2:40:22 PM CST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.41M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MOTT DAVID M Director | Purchase at price 4.99 per share. | Direct | 992,672 | Jan 21, 2025 |
| RODGERS RICHARD J. Director | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 55,000 | Jan 16, 2025 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.31 per share. | Direct | 221,309 | Jan 7, 2025 |
| RAAB MICHAEL G Chief Executive Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Direct | 20,625 | Jan 7, 2025 |
| MOTT DAVID M Director | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 55,000 | Dec 26, 2024 |
| MOTT DAVID M Director | Purchase at price 4.67 per share. | Direct | 996,580 | Dec 19, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.26 per share. | Direct | 131,620 | Dec 10, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Direct | 24,750 | Dec 10, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.38 per share. | Direct | 134,482 | Nov 25, 2024 |
| RENZ JUSTIN ANDREW Chief Financial Officer | Sale at price 4.79 per share. | Direct | 25,219 | Nov 20, 2024 |
| BLANKS ROBERT C. Officer | Sale at price 4.79 per share. | Direct | 23,690 | Nov 20, 2024 |
| WILLIAMS LAURA A Officer | Sale at price 4.79 per share. | Direct | 35,316 | Nov 20, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 4.79 per share. | Indirect | 34,444 | Nov 20, 2024 |
| GRAMMER ELIZABETH ESQ. Officer | Sale at price 4.79 per share. | Direct | 33,782 | Nov 20, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 4.79 per share. | Direct | 153,328 | Nov 20, 2024 |
| MOTT DAVID M Director | Purchase at price 4.62 per share. | Direct | 996,598 | Nov 13, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 4.90 per share. | Direct | 13,441 | Nov 11, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 6.10 per share. | Indirect | 165,743 | Nov 6, 2024 |
| ROSENBAUM DAVID PAUL Officer | Conversion of Exercise of derivative security at price 2.32 per share. | Indirect | 63,037 | Nov 6, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 5.95 per share. | Indirect | 161,673 | Nov 4, 2024 |
| ROSENBAUM DAVID PAUL Officer | Conversion of Exercise of derivative security at price 2.32 per share. | Indirect | 63,039 | Nov 4, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.91 per share. | Direct | 147,740 | Oct 28, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Direct | 24,750 | Oct 28, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 6.01 per share. | Direct | 45,075 | Oct 11, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 6.92 per share. | Direct | 342,983 | Sep 27, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 6.07 per share. | Direct | 18,210 | Sep 26, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 6.26 per share. | Indirect | 33,254 | Sep 13, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.61 per share. | Direct | 196,399 | Sep 11, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Direct | 34,650 | Sep 11, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 6.22 per share. | Direct | 46,635 | Aug 27, 2024 |
| RENZ JUSTIN ANDREW Chief Financial Officer | Sale at price 5.86 per share. | Direct | 30,995 | Aug 20, 2024 |
| BLANKS ROBERT C. Officer | Sale at price 5.86 per share. | Direct | 29,120 | Aug 20, 2024 |
| WILLIAMS LAURA A Officer | Sale at price 5.86 per share. | Direct | 43,437 | Aug 20, 2024 |
| FELSCH ROBERT ORA Officer | Sale at price 5.86 per share. | Direct | 20,904 | Aug 20, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 5.94 - 6.00 per share. | Indirect | 241,782 | Aug 20, 2024 |
| ROSENBAUM DAVID PAUL Officer | Sale at price 5.86 per share. | Indirect | 42,306 | Aug 20, 2024 |
| GRAMMER ELIZABETH ESQ. Officer | Sale at price 5.86 per share. | Direct | 41,544 | Aug 20, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.86 per share. | Direct | 188,848 | Aug 20, 2024 |
| ROSENBAUM DAVID PAUL Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Indirect | 20,302 | Aug 20, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.71 per share. | Direct | 7,018 | Aug 12, 2024 |
| FOSTER ERIC DUANE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 8, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.64 per share. | Direct | 169,314 | Jul 29, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Conversion of Exercise of derivative security at price 0.99 per share. | Direct | 29,700 | Jul 29, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 5.97 per share. | Direct | 44,768 | Jul 15, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 6.59 per share. | Direct | 15,223 | Jun 28, 2024 |
| BLANKS ROBERT C. Officer | Sale at price 5.96 per share. | Direct | 226,290 | Jun 21, 2024 |
| MOTT DAVID M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2024 |
| BERTRAND WILLIAM C JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2024 |
| RODGERS RICHARD J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2024 |
| RAAB MICHAEL G Chief Executive Officer | Sale at price 6.65 per share. | Direct | 232,743 | Jun 13, 2024 |
Related Tickers
AVTE Aerovate Therapeutics, Inc.
2.6200
+1.75%
CSCI COSCIENS Biopharma Inc.
2.7700
+2.21%
TENX Tenax Therapeutics, Inc.
6.00
-1.64%
BPMC Blueprint Medicines Corporation
114.05
-0.24%
CING Cingulate Inc.
4.5500
-4.01%
DNLI Denali Therapeutics Inc.
23.58
+0.73%
JANX Janux Therapeutics, Inc.
44.79
+5.36%
BEAM Beam Therapeutics Inc.
27.28
+5.29%
BNTX BioNTech SE
120.88
-0.23%
NVAX Novavax, Inc.
9.01
+2.27%